حلقة دابيفيرين
مراجع

↑  "WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection". www.who.int (بالإنجليزية). Archived from the original on 2024-07-29. Retrieved 2023-01-12.
↑  "Dapivirine - an overview | ScienceDirect Topics". www.sciencedirect.com. مؤرشف من الأصل في 2023-01-12. اطلع عليه بتاريخ 2023-01-12.
↑  admin (3 Mar 2016). "Dapivirine Ring". www.ipmglobal.org (بالإنجليزية). Archived from the original on 2024-08-29. Retrieved 2020-03-27.
↑  "South Africa". www.unaids.org (بالإنجليزية). Archived from the original on 2014-12-21. Retrieved 2020-04-24.
↑  Devlin, Bríd; Nuttall, Jeremy; Wilder, Susan; Woodsong, Cynthia; Rosenberg, Zeda (1 Dec 2013). "Development of dapivirine vaginal ring for HIV prevention". Antiviral Research (بالإنجليزية). 100: S3–S8. DOI:10.1016/j.antiviral.2013.09.025. ISSN:0166-3542. PMID:24188702. Archived from the original on 2024-04-18.
1 2  Devlin, Bríd; Nuttall, Jeremy; Wilder, Susan; Woodsong, Cynthia; Rosenberg, Zeda (1 Dec 2013). "Development of dapivirine vaginal ring for HIV prevention". Antiviral Research (بالإنجليزية). 100: S3–S8. DOI:10.1016/j.antiviral.2013.09.025. ISSN:0166-3542. PMID:24188702. Archived from the original on 2024-04-18.
↑  "Dapivirine Information for Providers". AIDSinfo (بالإنجليزية الأمريكية). Archived from the original on 2022-04-12. Retrieved 2020-04-24.
↑  "AIDSinfo | UNAIDS". aidsinfo.unaids.org. مؤرشف من الأصل في 2024-09-11. اطلع عليه بتاريخ 2020-04-26.
↑  "Dapivirine Information for Providers". AIDSinfo (بالإنجليزية الأمريكية). Archived from the original on 2022-04-12. Retrieved 2020-04-24.
↑  hseltzer (8 May 2014). "IPM Receives Worldwide Rights to HIV Prevention Medicine". www.ipmglobal.org (بالإنجليزية). Archived from the original on 2023-12-05. Retrieved 2020-03-27.
↑  hseltzer (8 May 2014). "IPM Receives Worldwide Rights to HIV Prevention Medicine". www.ipmglobal.org (بالإنجليزية). Archived from the original on 2023-12-05. Retrieved 2020-03-27.
↑  Roffe, Pedro; Tansey, Geoff (27 Apr 2012). Negotiating Health: Intellectual Property and Access to Medicines (بالإنجليزية). Taylor & Francis. ISBN:978-1-136-56049-1. Archived from the original on 2021-02-04.
1 2 3  Mensch, Barbara S.; Richardson, Barbra A.; Husnik, Marla; Brown, Elizabeth R.; Kiweewa, Flavia Matovu; Mayo, Ashley J.; Baeten, Jared M.; Palanee-Phillips, Thesla; van der Straten, Ariane (1 Feb 2019). "Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE". AIDS and Behavior (بالإنجليزية). 23 (2): 504–512. DOI:10.1007/s10461-018-2261-8. ISSN:1573-3254. PMC:6374159. PMID:30218318.
1 2 3 4 5 6 7  Vysloužil, Jakub; Kubová, Kateřina; Tkadlečková, Veronika Nováková; Vetchý, David (1 Sep 2019). "Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results". Acta Pharmaceutica (بالإنجليزية). 69 (3): 297–319. DOI:10.2478/acph-2019-0030. PMID:31259738. S2CID:195757338. Archived from the original on 2024-09-05.
1 2 3 4 5  Montgomery, Elizabeth T.; van der Straten, Ariane; Chitukuta, Miria; Reddy, Krishnaveni; Woeber, Kubashni; Atujuna, Millicent; Bekker, Linda-Gail; Etima, Juliane; Nakyanzi, Teopista (15 May 2017). "Acceptability and use of a dapivirine vaginal ring in a phase III trial". AIDS (بالإنجليزية الأمريكية). 31 (8): 1159–1167. DOI:10.1097/QAD.0000000000001452. ISSN:0269-9370. PMC:5557083. PMID:28441175.
↑  "Pooled efficacy analysis of two phase III trials of dapivirine vaginal ring (DVR) for the reduction of HIV-1 infection risk in HIV uninfected women in sub-Saharan Africa". programme.ias2017.org. 26 أبريل 2020. مؤرشف من الأصل في 2022-06-14. اطلع عليه بتاريخ 2020-04-26.
1 2  Vysloužil, Jakub; Kubová, Kateřina; Tkadlečková, Veronika Nováková; Vetchý, David (1 Sep 2019). "Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results". Acta Pharmaceutica (بالإنجليزية). 69 (3): 297–319. DOI:10.2478/acph-2019-0030. PMID:31259738. S2CID:195757338. Archived from the original on 2024-09-05.Vysloužil, Jakub; Kubová, Kateřina; Tkadlečková, Veronika Nováková; Vetchý, David (2019-09-01). "Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results". Acta Pharmaceutica. 69 (3): 297–319. doi:10.2478/acph-2019-0030. PMID 31259738. S2CID 195757338.
↑  Baeten, Jared M.; Palanee-Phillips, Thesla; Brown, Elizabeth R.; Schwartz, Katie; Soto-Torres, Lydia E.; Govender, Vaneshree; Mgodi, Nyaradzo M.; Matovu Kiweewa, Flavia; Nair, Gonasagrie (1 Dec 2016). "Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women". New England Journal of Medicine (بالإنجليزية). 375 (22): 2121–2132. DOI:10.1056/NEJMoa1506110. ISSN:0028-4793. PMC:4993693. PMID:26900902.
↑  Faria, Nuno R.; Vidal, Nicole; Lourenco, José; Raghwani, Jayna; Sigaloff, Kim C. E.; Tatem, Andy J.; Vijver, David A. M. van de; Pineda-Peña, Andrea-Clemencia; Rose, Rebecca (6 Dec 2019). "Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa". PLOS Pathogens (بالإنجليزية). 15 (12): e1007976. DOI:10.1371/journal.ppat.1007976. ISSN:1553-7374. PMC:6897401. PMID:31809523.
1 2  Penrose, Kerri J.; Wallis, Carole L.; Brumme, Chanson J.; Hamanishi, Kristen A.; Gordon, Kelley C.; Viana, Raquel V.; Harrigan, P. Richard; Mellors, John W.; Parikh, Urvi M. (1 Feb 2017). "Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa". Antimicrobial Agents and Chemotherapy (بالإنجليزية). 61 (2). DOI:10.1128/AAC.01805-16. ISSN:0066-4804. PMC:5278732. PMID:27895013.
↑  Englund, Harri (26 Apr 2011). Christianity and Public Culture in Africa (بالإنجليزية). Ohio University Press. ISBN:978-0-8214-1945-8. Archived from the original on 2024-09-11.
↑  Montgomery, Elizabeth T.; van der Straten, Ariane; Chitukuta, Miria; Reddy, Krishnaveni; Woeber, Kubashni; Atujuna, Millicent; Bekker, Linda-Gail; Etima, Juliane; Nakyanzi, Teopista (15 May 2017). "Acceptability and use of a dapivirine vaginal ring in a phase III trial". AIDS (بالإنجليزية الأمريكية). 31 (8): 1159–1167. DOI:10.1097/QAD.0000000000001452. ISSN:0269-9370. PMC:5557083. PMID:28441175.Montgomery, Elizabeth T.; van der Straten, Ariane; Chitukuta, Miria; Reddy, Krishnaveni; Woeber, Kubashni; Atujuna, Millicent; Bekker, Linda-Gail; Etima, Juliane; Nakyanzi, Teopista; Mayo, Ashley J.; Katz, Ariana (2017-05-15). "Acceptability and use of a dapivirine vaginal ring in a phase III trial". AIDS. 31 (8): 1159–1167. doi:10.1097/QAD.0000000000001452. ISSN 0269-9370. PMC 5557083. PMID 28441175.
1 2 3 4 5 6  Laborde, Nicole D.; Pleasants, Elizabeth; Reddy, Krishnaveni; Atujuna, Millicent; Nakyanzi, Teopista; Chitukuta, Miria; Naidoo, Sarita; Palanee-Phillips, Thesla; Baeten, Jared M. (1 Feb 2018). "Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex". AIDS and Behavior (بالإنجليزية). 22 (2): 437–446. DOI:10.1007/s10461-017-1977-1. ISSN:1573-3254. PMC:5866044. PMID:29151197.
↑  Laborde, Nicole D.; Pleasants, Elizabeth; Reddy, Krishnaveni; Atujuna, Millicent; Nakyanzi, Teopista; Chitukuta, Miria; Naidoo, Sarita; Palanee-Phillips, Thesla; Baeten, Jared M. (1 Feb 2018). "Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex". AIDS and Behavior (بالإنجليزية). 22 (2): 437–446. DOI:10.1007/s10461-017-1977-1. ISSN:1573-3254. PMC:5866044. PMID:29151197.Laborde, Nicole D.; Pleasants, Elizabeth; Reddy, Krishnaveni; Atujuna, Millicent; Nakyanzi, Teopista; Chitukuta, Miria; Naidoo, Sarita; Palanee-Phillips, Thesla; Baeten, Jared M.; Montgomery, Elizabeth T.; On behalf of the MTN-020/ASPIRE Study Team (2018-02-01). "Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex". AIDS and Behavior. 22 (2): 437–446. doi:10.1007/s10461-017-1977-1. ISSN 1573-3254. PMC 5866044. PMID 29151197.{{cite journal}}: CS1 maint: numeric names: authors list (link)
1 2 3 4 5  Chitukuta، Miria؛ Duby، Zoe؛ Katz، Ariana؛ Nakyanzi، Teopista؛ Reddy، Krishnaveni؛ Palanee-Phillips، Thesla؛ Tembo، Tchangani؛ Etima، Juliane؛ Musara، Petina (2 نوفمبر 2019). "Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa". Culture, Health & Sexuality. ج. 21 ع. 11: 1209–1224. DOI:10.1080/13691058.2018.1552989. ISSN:1369-1058. PMC:6639142. PMID:30657023.
↑  "MTN-036/IPM 047". AVAC (بالإنجليزية). 17 Feb 2016. Archived from the original on 2020-03-27. Retrieved 2020-03-27.
↑  "MTN-030/IPM 041 | Microbicide Trials Network". www.mtnstopshiv.org. اطلع عليه بتاريخ 2020-03-28.
↑  "MTN-044 | Microbicide Trials Network". mtnstopshiv.org. اطلع عليه بتاريخ 2020-03-28.
↑  admin (3 Mar 2016). "DS003-Dapivirine Ring". www.ipmglobal.org (بالإنجليزية). Retrieved 2020-03-27.
↑  "MTN-013/IPM 026 | Microbicide Trials Network". www.mtnstopshiv.org. اطلع عليه بتاريخ 2020-03-28.
بوابة طب
رسم تخطيطي يوضح آليات عمل الأدوية المضادة للفيروسات القهقرية المختلفة المستخدمة لعلاج فيروس نقص المناعة البشرية. DPV هو نوع من مثبطات النسخ العكسي.
العدد الإجمالي للبالغين المصابين بفيروس نقص المناعة البشرية في جنوب أفريقيا بين عامي 1990 و2018 حسب الجنس.
المسيحية هي الديانة الأكثر ممارسة في منطقة جنوب الصحراء الكبرى في أفريقيا.